UMBC researchers clarify role of SMYD3 enzyme in prostate cancer progression
An enzyme called SMYD3 may be involved in prostate cancer’s progression to a more dangerous and aggressive stage. The enzyme’s newly confirmed role makes it a prime potential drug target for preventing metastatic disease. Continue Reading UMBC researchers clarify role of SMYD3 enzyme in prostate cancer progression